Linked Life Data

1582684

Source:http://linkedlifedata.com/resource/pubmed/id/1582684

Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:1582684rdf:typepubmed:Citationlld:pubmed
pubmed-article:1582684lifeskim:mentionsumls-concept:C0003232lld:lifeskim
pubmed-article:1582684lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:1582684lifeskim:mentionsumls-concept:C0043406lld:lifeskim
pubmed-article:1582684lifeskim:mentionsumls-concept:C0020835lld:lifeskim
pubmed-article:1582684lifeskim:mentionsumls-concept:C0020852lld:lifeskim
pubmed-article:1582684lifeskim:mentionsumls-concept:C0949691lld:lifeskim
pubmed-article:1582684lifeskim:mentionsumls-concept:C0546816lld:lifeskim
pubmed-article:1582684lifeskim:mentionsumls-concept:C1704632lld:lifeskim
pubmed-article:1582684lifeskim:mentionsumls-concept:C0871261lld:lifeskim
pubmed-article:1582684lifeskim:mentionsumls-concept:C2911692lld:lifeskim
pubmed-article:1582684lifeskim:mentionsumls-concept:C1706817lld:lifeskim
pubmed-article:1582684pubmed:issue2lld:pubmed
pubmed-article:1582684pubmed:dateCreated1992-6-12lld:pubmed
pubmed-article:1582684pubmed:abstractTextThe IgA and IgG antibody response to plasmid-encoded outer membrane proteins was studied in 59 patients with yersinia-associated spondylarthropathy during 15 months of follow-up. Initially, all patients had specific IgA and IgG antibodies to the 36 and 46 kDa and 30% also to the 26 and 58 kDa released proteins, which correlated with the finding of virulent Yersinia bacilli in intestinal biopsies. IgA disappeared in 69% of untreated patients after nine months and persisted in 31% after one year. IgA disappeared within three to six months in 81% of the patients treated with antibiotics for four to six weeks and persisted in 6% after one year (p less than 0.002). IgG antibodies to the 36 and 46 kDa outer membrane proteins persisted in 80% of all patients. Disappearance of IgA was coupled with disappearance of yersinia from intestinal biopsies.lld:pubmed
pubmed-article:1582684pubmed:languageenglld:pubmed
pubmed-article:1582684pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1582684pubmed:citationSubsetIMlld:pubmed
pubmed-article:1582684pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1582684pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1582684pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1582684pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1582684pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1582684pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1582684pubmed:statusMEDLINElld:pubmed
pubmed-article:1582684pubmed:issn0300-8126lld:pubmed
pubmed-article:1582684pubmed:authorpubmed-author:de KoningJJlld:pubmed
pubmed-article:1582684pubmed:authorpubmed-author:Hoogkamp-Kors...lld:pubmed
pubmed-article:1582684pubmed:authorpubmed-author:FestenJ JJJlld:pubmed
pubmed-article:1582684pubmed:authorpubmed-author:HeesemannJJlld:pubmed
pubmed-article:1582684pubmed:authorpubmed-author:HoutmanP MPMlld:pubmed
pubmed-article:1582684pubmed:authorpubmed-author:van OyenP LPLlld:pubmed
pubmed-article:1582684pubmed:issnTypePrintlld:pubmed
pubmed-article:1582684pubmed:volume20lld:pubmed
pubmed-article:1582684pubmed:ownerNLMlld:pubmed
pubmed-article:1582684pubmed:authorsCompleteYlld:pubmed
pubmed-article:1582684pubmed:pagination53-7lld:pubmed
pubmed-article:1582684pubmed:dateRevised2004-11-17lld:pubmed
pubmed-article:1582684pubmed:meshHeadingpubmed-meshheading:1582684-...lld:pubmed
pubmed-article:1582684pubmed:meshHeadingpubmed-meshheading:1582684-...lld:pubmed
pubmed-article:1582684pubmed:meshHeadingpubmed-meshheading:1582684-...lld:pubmed
pubmed-article:1582684pubmed:meshHeadingpubmed-meshheading:1582684-...lld:pubmed
pubmed-article:1582684pubmed:meshHeadingpubmed-meshheading:1582684-...lld:pubmed
pubmed-article:1582684pubmed:meshHeadingpubmed-meshheading:1582684-...lld:pubmed
pubmed-article:1582684pubmed:meshHeadingpubmed-meshheading:1582684-...lld:pubmed
pubmed-article:1582684pubmed:meshHeadingpubmed-meshheading:1582684-...lld:pubmed
pubmed-article:1582684pubmed:meshHeadingpubmed-meshheading:1582684-...lld:pubmed
pubmed-article:1582684pubmed:meshHeadingpubmed-meshheading:1582684-...lld:pubmed
pubmed-article:1582684pubmed:meshHeadingpubmed-meshheading:1582684-...lld:pubmed
pubmed-article:1582684pubmed:meshHeadingpubmed-meshheading:1582684-...lld:pubmed
pubmed-article:1582684pubmed:meshHeadingpubmed-meshheading:1582684-...lld:pubmed
pubmed-article:1582684pubmed:meshHeadingpubmed-meshheading:1582684-...lld:pubmed
pubmed-article:1582684pubmed:meshHeadingpubmed-meshheading:1582684-...lld:pubmed
pubmed-article:1582684pubmed:meshHeadingpubmed-meshheading:1582684-...lld:pubmed
pubmed-article:1582684pubmed:meshHeadingpubmed-meshheading:1582684-...lld:pubmed
pubmed-article:1582684pubmed:articleTitleInfluence of antibiotics on IgA and IgG response and persistence of Yersinia enterocolitica in patients with Yersinia-associated spondylarthropathy.lld:pubmed
pubmed-article:1582684pubmed:affiliationLaboratory for Public Health, Leeuwarden, The Netherlands.lld:pubmed
pubmed-article:1582684pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1582684lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1582684lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1582684lld:pubmed